CancerCare Manitoba Foundation
STAR RATINGCi's Star Rating is calculated based on the following independent metrics: |
✔+
FINANCIAL TRANSPARENCY
Audited financial statements for current and previous years available on the charity’s website.
B-
RESULTS REPORTING
Grade based on the charity's public reporting of the work it does and the results it achieves.
n/r
DEMONSTRATED IMPACT
The demonstrated impact per dollar Ci calculates from available program information.
NEED FOR FUNDING
Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.
82%
CENTS TO THE CAUSE
For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 82 cents are available for programs.
My anchor
OVERVIEW
About CancerCare Manitoba Foundation:
CancerCare Manitoba is a 3-star charity. It has a B- results reporting grade, which is below average. Its overhead spending is within Ci’s reasonable range and it has reserve funds to cover its program costs for eight years and seven months.
Founded in 1997, CancerCare Manitoba Foundation (CCMF) fundraises for CancerCare Manitoba (CCMB). CCMB is Manitoba’s provincially mandated agency for cancer and blood disorders. Contributions from CCMF help fund projects that are not eligible for government funding or that funding is not available for. These include prevention, early detection, clinical trials, and research. CCMF reports that all funds raised and donated remain in Manitoba. Since 2000, CCMF has granted over $208m to CCMB. CCMF funds four programs: Patient Experience, Local Research, Clinical Trials, and Prevention, Risk Reduction, and Awareness.
The following program information is from CCMF’s annual report for the fiscal year ending March 2023 (F2023). CCMF’s annual report for F2024 was not available at the time of this update. The program spending breakdown CCMF provides in its annual report does not reconcile with its audited financial statement. Ci reports the percentages for program spending from the F2023 annual report without the dollar values.
CCMF reported that 48% of its program spending went to Patient Experience in F2023. This program focuses on supporting cancer patients and their families. These include educational resources and after-care programs to help patients. Alongside the Government of Manitoba, CCMF is providing funding for a new Centre of Hope at the Western Manitoba Cancer Centre. The new Centre will help patients and families receive emotional and physical support they need.
CancerCare Manitoba Foundation spent 46% of program spending on Local Research in F2023. CCMB reports that it has over 70 scientists researching cancer and blood disorders. CCMB has three interrelated research disciplines: Basic and Translational Research, Clinical Research, and Health Services Research.
CCMF spent 4% of program spending on Clinical Trials in F2023. Over 1,700 patients at CancerCare Manitoba are currently followed on clinical trials. CCMB reports that each year around 300 Manitobans enrol in around 120 clinical trials.
CCMF spent 2% of program spending on Prevention, Risk Reduction, and Awareness in F2023. This program focuses on ensuring access to screening programs and educational tools. The charity reports that if all Manitobans started eating healthy today, 1,300 cancer cases could be prevented in 2038.
My anchor
Results and Impact
CancerCare Manitoba Foundation reports that the donations it receives make a significant difference in changing the course of cancer in Manitoba. The charity reports that:
The five-year cancer survival rate is 64%, up from 55% in the early 1990s.
50% decline in prostate cancer deaths since 1995.
48% decline in breast cancer deaths since the 1980s.
While Ci highlights these key outcomes, they may not be a complete representation of CancerCare Manitoba Foundation’s results and impact.
This charity is not yet rated on impact (n/r).
My anchor
Finances
In the fiscal year ending March 2024 (F2024), CCMF received $21.1m in donations and special events revenue. CCMF also made $10.3m in investment income (32% of total revenue). Administrative costs are 7% of total revenue (excluding investment income) and fundraising costs are 11% of donations. Overhead spending is 18%, which is within Ci’s reasonable range. For every dollar donated, 82 cents are available for the cause. In F2024, CancerCare Manitoba Foundation granted $11.2m (35% of total revenue) to CancerCare Manitoba.
In F2024, CCMF had a surplus of $16.9m and reported no spending on capital expenditures.
At the end of F2024, CCMF has $103.5m in reserve funds. $13.8m of these funds are donor endowed. Excluding donor-endowed funds, CCMF has enough reserve funds to cover 857% or eight years and seven months of its annual program costs.
This charity report is an update that was sent to CancerCare Manitoba Foundation for review. Changes and edits may be forthcoming.
Updated on July 19, 2024 by Thea Clark.
Financial Review
Fiscal year ending March
|
2024 | 2023 | 2022 |
|---|---|---|---|
| Administrative costs as % of revenues | 7.2% | 6.8% | 10.1% |
| Fundraising costs as % of donations | 11.0% | 10.6% | 21.2% |
| Total overhead spending | 18.2% | 17.4% | 31.3% |
| Program cost coverage (%) | 856.7% | 578.1% | 962.5% |
Summary Financial StatementsAll figures in $000s |
2024 | 2023 | 2022 |
|---|---|---|---|
| Donations | 16,831 | 14,700 | 6,733 |
| Special events | 4,253 | 4,817 | 4,301 |
| Investment income | 10,295 | 330 | 1,649 |
| Other income | 616 | 237 | 92 |
| Total revenues | 31,996 | 20,084 | 12,775 |
| Grants | 11,159 | 13,515 | 7,764 |
| Administrative costs | 1,564 | 1,349 | 1,118 |
| Fundraising costs | 2,326 | 2,073 | 2,343 |
| Total spending | 15,049 | 16,936 | 11,225 |
| Cash flow from operations | 16,947 | 3,148 | 1,550 |
| Capital spending | 0 | 0 | 0 |
| Funding reserves | 103,498 | 87,163 | 81,500 |
Note: UNREALIZED GAIN (LOSS) ON INVESTMENTS: Ci included unrealized gain (loss) on investments in investment income, affecting total revenue by $6.7m in F2024, ($2.1m) in F2023, and ($1.7m) in F2022. DEFERRED CONTRIBUTIONS: Ci included deferred contributions in other revenue, affecting total revenue by $47k in F2024, ($861) in F2023, and $50k in F2022. SPECIAL EVENTS: Instead of reporting net events revenue in revenues, Ci reports events revenues under revenues and events expenses under expenses. This increased total revenue and expenses by $1.1m in F2024, $1.0m in F2023, and $1.3m in F2022.
Salary Information
$350k + |
0 |
$300k - $350k |
0 |
$250k - $300k |
0 |
$200k - $250k |
1 |
$160k - $200k |
0 |
$120k - $160k |
2 |
$80k - $120k |
6 |
$40k - $80k |
1 |
< $40k |
0 |
Information from most recent CRA Charities Directorate filings for F2023
My anchor
Comments & Contact
Comments added by the Charity:
Charity Contact
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 204-787-4143